Executives from MAPS, NORML, and MPP to Celebrate DEA Rescheduling of Cannabis to Schedule III Drug and Debunk Myths Executives Read More
July 12, 2025
Easy come, easy go. Yesterday, shares of cannabis companies like Canopy Growth (NASDAQ: CGC), Tilray Brands (NASDAQ: TLRY), and Cronos Read More
The move to stop equating marijuana with heroin reverses decades of brain-dead policy. But will it help vulnerable Americans, or Read More
Tesla’s Downsizing Worries Supercharger Industry Widespread layoffs within the Tesla unit are a blow to efforts to build out Read More
Moving marijuana to Schedule III, as the DEA plans to do, leaves federal pot prohibition essentially untouched. The Justice Department Read More
A more cannabis-friendly U.S. would offer high growth potential for these stocksYesterday brought a significant rally for cannabis stocks Read More
The Justice Department proposal would recognize the medical uses of cannabis but wouldn’t legalize it for recreational use. If Read More
Did Tilray Brands (NASDAQ:TLRY) have a blockbuster earnings report? Did Aurora Cannabis (NASDAQ:ACB) suddenly launch a new edibles Read More
Tesla’s Downsizing Worries Supercharger Industry Widespread layoffs within the Tesla unit are a blow to efforts to build out Read More
PHOENIX Facing softening support from a left-leaning voting group that will be crucial to his reelection hopes in November, President Read More